Principal Investigator: David Turok
Keywords: breastfeeding , Mirena , IUD , Postpartum Department: DFPM-Family Practice
IRB Number: 00062844 Co Investigator: David Turok
Specialty: OB/Gyn, General
Sub Specialties: Contraception and Family Planning
Recruitment Status: Completed

Contact Information

Maria  Masters

Simple Summary

Study focus is to determine breast feeding continuation at 8 weeks in women randomized to immediate post-placental vs. delayed (4-8 weeks) postpartum Mirena IUD insertion. And to evaluate potential delayed in lactogenesis caused by immediate postpartum insertion of the Mirena IUD.

Inclusion Criteria

Patients will be offered inclusion in the study if they are

  • Healthy, 18-40 year old pregnant women
  • Intend to breastfeed
  • Desire the LNG IUD as their method of contraception
  • Qualify for the LARC postpartum contraception program
  • Agree to be randomized to early versus standard postpartum insertion
  • Have delivered a healthy term infant (37 weeks gestation)
  • Willing to complete all study related procedures, visits and questionnaires

Exclusion Criteria

  • Chorioamnionitis
  • Obstetric complications including transfusion
  • Severe pregnancy induced hypertension
  • Prolonged hospitalization
  • Coagulopathy
  • Liver disease
  • Undiagnosed genital bleeding, or other relative contraindication to LNG IUD insertion (known or suspected pregnancy, uterine cavity abnormality, known, suspected, or history of breast cancer, or hypersensitivity to any of the components in the LNG IUD).

Participant Reimbursement

$40.00 for all participants, if they are participating in the breast milk collection aspect of the study they will received an additional $40 and if they participate in the infant blood collection aspect of the study they will receive an additional $50.